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Liver cancer is the sixth most frequently diagnosed cancer and, particularly, Hepatocellular Carcinoma
(HCC) represents more than 90% of primary liver cancers. Clinicians assess each patient’s treatment on
the basis of evidence-based medicine, which may not always apply to a specific patient, given the biolog-
ical variability among individuals. Over the years, and for the particular case of Hepatocellular Carcinoma,
some research studies have been developing strategies for assisting clinicians in decision making, using
computational methods (e.g. machine learning techniques) to extract knowledge from the clinical data.
However, these studies have some limitations that have not yet been addressed: some do not focus
entirely on Hepatocellular Carcinoma patients, others have strict application boundaries, and none con-
siders the heterogeneity between patients nor the presence of missing data, a common drawback in
healthcare contexts. In this work, a real complex Hepatocellular Carcinoma database composed of hetero-
geneous clinical features is studied. We propose a new cluster-based oversampling approach robust to
small and imbalanced datasets, which accounts for the heterogeneity of patients with Hepatocellular
Carcinoma. The preprocessing procedures of this work are based on data imputation considering appro-
priate distance metrics for both heterogeneous and missing data (HEOM) and clustering studies to assess
the underlying patient groups in the studied dataset (K-means). The final approach is applied in order to
diminish the impact of underlying patient profiles with reduced sizes on survival prediction. It is based
on K-means clustering and the SMOTE algorithm to build a representative dataset and use it as training
example for different machine learning procedures (logistic regression and neural networks). The results
are evaluated in terms of survival prediction and compared across baseline approaches that do not con-
sider clustering and/or oversampling using the Friedman rank test. Our proposed methodology coupled
with neural networks outperformed all others, suggesting an improvement over the classical approaches
currently used in Hepatocellular Carcinoma prediction models.
 2015 Elsevier Inc. All rights reserved.1. Introduction
For the past few years, we have been witnessing an exponential
growth of cancer incidence and related deaths worldwide. Solely in
2012, the World Health Organization (WHO) reported about 14.1
millions of new cancer cases and 8.2 millions of deaths [1]. Livercancer was the sixth most frequently diagnosed cancer and the
second cause of cancer-related deaths worldwide, accounting for
9.1% of all deaths [1,2]. Hepatocellular Carcinoma (HCC) represents
more than 90% of primary liver cancers and it is a major global
health problem [3]. In Portugal, liver cancer did not figure among
the most frequently diagnosed cancers. Nevertheless, it was the
seventh leading cause of cancer mortality, being responsible for
3.8% of cancer deaths [1]. Some studies regarding this pathology
have emerged, attempting to define its dimension in Portugal.
According to the work of Tato Marinho et al. [4], HCC hospital
admissions tripled from 1993 to 2005, with the overall costs of
admission rising proportionally. In 2010, the Portuguese Society
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by approximately 70% by the end of 2015, seeking a greater
national awareness regarding liver diseases [5].
Data-driven statistical research has become an attractive com-
plement for clinical research. Survival prediction is one of the most
challenging tasks addressed by the medical research communities
[6–10]. It consists in analyzing a substantial amount of clinical
data, drawing patterns and conclusions from those data, and using
them to determine the survivability of a particular patient suffer-
ing from a given disease over a certain period of time. However,
modeling and predicting disease outcomes may turn to be a diffi-
cult quest due to two main reasons: one relates to the dataset’s
size, while the other concerns its complexity.
Regarding the first topic, several authors consider that small
datasets limit the scope of data mining techniques, since they
may not provide enough information to accomplish the learning
task of some algorithms [11,12]. Nevertheless, in real-life prob-
lems, specially in healthcare contexts, relatively small datasets
are normal, specifically for less common diseases.
Dataset complexity can be derived from the characteristics of
the data that composes the dataset. For datasets with heteroge-
neous data, the assumptions of some data mining algorithms
may not be verified, and thus they might not be applicable [13].
For datasets with Missing Data (MD) (i.e., with variables containing
a percentage of missing values and/or with records where several
variables are incomplete), data mining algorithms may produce
biased models and estimates, which decreases their performance
[14].
Furthermore, patient heterogeneity is also an important topic to
consider. In HCC guidelines, as in general cancer research, patient
survival and prognosis are related to tumor stage [3]. However,
growing studies regarding other diseases have pointed out the
need to expand staging systems for predicting the outcome of can-
cer patients [15]. A more robust approach to study heterogeneous
groups is cluster analysis. The main advantage in this type of
approaches is that they generate homogeneous groups, with simi-
lar prognostic features, that map onto similar survival patterns,
thus allowing a more accurate prediction.
The aim of this work is to start from the previously published
literature on the application of computational techniques for HCC
disease and assess to what extent they could be generalized for
HCC dataset with complex characteristics. These characteristics
consist of a relative small dataset size (165 patients), an heteroge-
neous set of predictive variables (49 clinical variables, including
ratio-scaled, dichotomous and ordinal variables), a high percentage
of missing values (an overall MD rate of 10.22% with only eight
patients have complete information) and an expected heterogene-
ity between patients, due to the range of values in the considered
values and the class imbalance for the HCC dataset (as detailed in
Section 3.1). The majority of works on HCC are based on Neural
Networks (NN) and Logistic Regression (LR) models (please refer
to Section 2.2). However, all of these works ignore patient hetero-
geneity and the presence of missing data. In this work, both NN
and LR are applied to a real incomplete HCC dataset, addressing
the limitations found in previous research works. These algorithms
are combined with four different approaches. In the first approach,
the prediction models directly use the obtained dataset after a data
imputation phase, while in the second approach the obtained data-
set (after the clean-up procedure) is oversampled using SMOTE
(Synthetic Minority Over-sampling Technique) algorithm [16].
The other two approaches are based on a new methodology pro-
posed in this article, which consists in using a dataset produced
by a cluster-based oversampling method. The third approach gen-
erates R different datasets and properly merges them into a unique
representative dataset, M, which is used to build the prediction
models. Finally, the fourth approach considers a combination ofeach R previously oversampled dataset with the representative
dataset M. This last approach constructs a survival prediction
model for each combination of R datasets with the representative
dataset, and achieves the final classification results through major-
ity voting. These four approaches are tested for both data mining
algorithms (NN and LR) using a Leave-One-Out Cross Validation
(LOO-CV) approach, which is appropriate for small sample data-
sets. For more information, please consult Section 4.
To the best of authors’ knowledge, this kind of methodology has
never been proposed and applied for a HCC dataset presenting
these characteristics. This topic is fully detailed in Section 3.
Regarding Accuracy, Area Under the ROC Curve (AUC) and
F-measure as performance indicators, the obtained results for our
cluster-based oversampling approaches revealed statistical
significant improvements on the performance of the NN algorithm,
in comparison to the other two most commonly used approaches,
proving that our methodology is generally feasible to design sur-
vival prediction models for HCC disease.
The remainder of this paper is organized as follows: Section 2
presents a brief description about HCC disease and illustrates some
related works in the area. Section 3 outlines the methodological
steps used in this project concerning the four project phases: Data
collection, Data imputation, Cluster-based oversampling and
Survival prediction. Section 4 reports the collected results and,
finally, Section 5 presents the conclusions and proposals for further
studies.2. Computational approaches for HCC
In order to predict 1-year survival of HCC patients, it is impor-
tant to understand some underlying aspects of this pathology
and to review the previous related works on the application of
computational methods to HCC disease.
2.1. Notions of HCC disease
A Carcinoma is a type of cancer that arises when an epithelial
cell undergoes a malignant transformation. In particular, when
the source of cancer is an epithelial cell cancer of the liver, known
as hepatocyte, the cancer is called hepatocellular carcinoma (HCC)
[17,3]. HCC may have different growth patterns. Some malignant
tumors begin as a single tumor that grows larger and only spread
to other parts of the liver in later stages. A second pattern is
described by the appearance of small cancerous nodules scattered
throughout the liver. This pattern is particularly common in
patients with cirrhosis, and the most frequently detected in
Portugal.
Approximately 90% of HCCs are associated with a known under-
lying risk factor [17,3]. The most frequent factors include chronic
viral hepatitis (types B and/or C) and cirrhosis. Regarding both hep-
atitis virus, their corresponding main markers involve the mea-
surements of specific antigens and antibodies, while cirrhosis is
usually assessed with Child-Pugh (CP) score [18], which employs
five clinical measures of liver disease (Total Bilirubin, Albumin,
Encephalopathy, Ascites and Prothrombin Time). Cirrhosis is pre-
sent in over 80% of HCC cases, being clearly identified as the main
precursor lesion of this pathology.
2.2. Previous related works
Machine learning algorithms are computational techniques par-
ticularly well-suited to cancer research [19]. They are frequently
used to analyze the available data about the disease under study
(i.e. existing clinical trials) and produce new conclusions regarding
a particular patient.
Table 1
HCC developed works (n.a. – not applicable). In spite of the fact that the first work illustrated in Section 2.2. is one of the pioneers in the HCC area [20], it has not been covered in
this table since the evaluation metrics are not provided.
Ho et al. [21] Chiu et al. [22] Shi et al. [23]
Objective Disease-free survival after
hepatic reSection (1st year)
Mortality after
hepatic reSection (1st year)
Mortality after
HCC surgery
Sample size 427 434 22.926
MD No No No
NN Accuracy n.a n.a 96%
AUC 0.777 0.991 0.82
Sensitivity 0.787 0.997 0.784
Specificity 0.542 0.962 0.946
LR Accuracy n.a n.a 84%
AUC 0.772 0.890 0.730
Sensitivity 0.754 0.986 0.626
Specificity 0.583 0.346 0.919
Fig. 1. Proposed methodology.
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been previously performed [20–23]. In the first work [20], the
authors introduced a regression model to diagnose liver disorders,
having as a base a 200 cirrhotic patients dataset. Each clinical trial
was composed by different types of variables, including laboratory
tests and histopathological data. Nevertheless, and due to the fact
that the number of HCC patients was not significant (only 5% of the
cirrhotic patients), their results were very preliminary and not suf-
ficient to validate the system. Besides, they did not consider any
treatment for missing input values. In the second work, Ho et al.
[21] attempted to establish a model to describe free-disease sur-
vival after hepatic resection, regarding a particular temporal line
(1, 3 and 5 years). They have reviewed a study population of 482
HCC patients, in order to collect each patient’s demographics, risk
factors and several other variables related to the laboratory tests,
tumor stage and the resection procedure itself. Three prediction
models were tested: NN, LR and Decision Trees (DT). This work’s
results showed that NN outperformed the other two models in
the great majority of training and validation groups. Despite prov-
ing good results, this work only considered HCC patients who have
received hepatic resection, discarding patients in other stages of
HCC disease. Thus, this works neglects patient heterogeneity,
which is an added factor of complexity, considered in this work.
Furthermore, this work also completely ignores the missing data
perspective, which does not accurately tackle the true reality of
these contexts.
Following this research work, the same authors compared the
performance of NN and LR models to predict mortality of HCC
patients who underwent liver resection [22]. The only relevant dif-
ference between these two works is the response of the algo-
rithms: one seeks to predict disease-free survival and the other
intends to predict if the patient is alive or dead in the considered
periods (may he be disease-free or not). In another recent work
[23], Shi et al. evaluated the use of NN and LR models for predicting
in-hospital mortality in HCC surgery patients: the analysis was
limited to patients who underwent a HCC surgery and clinical
records with missing data were directly discarded. For both latter
works, the previously detected limitations can also be found: they
neglect patient heterogeneity and missing data as well.
Table 1 resumes the developed works in the HCC area. Perform-
ing an analysis of the Table 1 and, in conclusion, despite the grow-
ing interest and recent advances in the study of HCC, none of the
studies so far as considered such a focused and complete approach
to HCC data as the one proposed in this work. We conduct a study
of patients’ survivability only for HCC disease, prior to any
therapeutic constraint, regarding a context with heterogeneous
and missing data, and accounting for patient’s heterogeneity, thus
traducing the reality of most clinical contexts.3. Methodology
This section describes the different four stages that compose the
proposed methodology (see Fig. 1): Data collection, Data imputa-
tion, Cluster-based oversampling and Survival prediction. The
main aspects of each stage are analyzed below.3.1. Data collection
The first stage has been performed by the Service of Internal
Medicine A of the Coimbra’s Hospital and Universitary Centre
(CHUC). It concerns the analysis of demographic, risk factor, labo-
ratory and overall survival features from a set of N ¼ 165 patients
diagnosed with HCC. The resulting dataset comprises n ¼ 49
features. They have been selected according to the EASL-EORTC
(European Association for the Study of the Liver – European Organ-
isation for Research and Treatment of Cancer) Clinical Practice
Guidelines [3], the current state-of-the art on the management of
HCC, in collaboration with a team of clinicians from CHUC’s Service
of Internal Medicine A. This dataset includes the clinical features
considered to be the most significant to the clinicians’ decision
process, when choosing the most suitable therapeutic strategies
and predicting its outcomes for each patient. A detailed description
of the HCC dataset is presented in Table 2, which shows each fea-
ture’s type/scale, range, statistics (mean/mode) and missing rate
percentage. This is a heterogeneous dataset, with twenty-three
quantitative variables (all ratio scaled) and twenty-six qualitative
variables. Overall, the missing data represents 10.22% of the whole
dataset and only eight patients have complete information in all
the fields (4.85%).
The survival target variable is encoded as a binary variable with
values 0 and 1, which respectively means that a patient did not
survive or survived. This work is focused on the 1-year survivabil-
ity prediction for HCC and, accordingly, the dataset’s class distribu-
tion presents 63 cases labeled as 0 (dead) and the remaining 102
cases as 1 (alive).3.2. Data imputation
In our methodology, this stage entails the process of ensuring
that there are not inconsistencies in the collected data, i.e., missing
Table 2
Characterization of CHUC’s hepatocellular carcinoma data. The dataset contains N ¼ 165 records of n ¼ 49 clinical variables, considered important to the clinicians decision
process.
Prognostic factors Type/scale Range Mean or mode Missingness (%)
Gender Qualitative/dichotomous 0/1 1 0
Symptoms Qualitative/dichotomous 0/1 1 10.91
Alcohol Qualitative/dichotomous 0/1 1 0
HBsAg Qualitative/dichotomous 0/1 0 10.3
HBeAg Qualitative/dichotomous 0/1 0 23.64
HBcAb Qualitative/dichotomous 0/1 0 14.55
HCVAb Qualitative/dichotomous 0/1 0 5.45
Cirrhosis Qualitative/dichotomous 0/1 1 0
Endemic countries Qualitative/dichotomous 0/1 0 23.64
Smoking Qualitative/dichotomous 0/1 1 24.85
Diabetes Qualitative/dichotomous 0/1 0 1.82
Obesity Qualitative/dichotomous 0/1 0 6.06
Hemochromatosis Qualitative/dichotomous 0/1 0 13.94
AHT Qualitative/dichotomous 0/1 0 1.82
CRI Qualitative/dichotomous 0/1 0 1.21
HIV Qualitative/dichotomous 0/1 0 8.48
NASH Qualitative/dichotomous 0/1 0 13.33
Esophageal varices Qualitative/dichotomous 0/1 1 31.52
Splenomegaly Qualitative/dichotomous 0/1 1 9.09
Portal hypertension Qualitative/dichotomous 0/1 1 6.67
Portal vein thrombosis Qualitative/dichotomous 0/1 0 1.82
Liver metastasis Qualitative/dichotomous 0/1 0 2.42
Radiological hallmark Qualitative/dichotomous 0/1 1 1.21
Age at diagnosis Quantitative/ratio 20–93 64.69 0
Grams/day Quantitative/ratio 0–500 71.01 29.09
Packs/year Quantitative/ratio 0–510 20.46 32.12
Performance status Qualitative/ordinal 0, 1, 2, 3, 4 0 0
Encefalopathy Qualitative/ordinal 1, 2, 3 1 0.61
Ascites Qualitative/ordinal 1, 2, 3 1 1.21
INR Quantitative/ratio 0.84–4.82 1.42 2.42
AFP Quantitative/ratio 1.2–1,810,346 19299.95 4.85
Hemoglobin Quantitative/ratio 5–18.7 12.88 1.82
MCV Quantitative/ratio 69.5–119.6 95.12 1.82
Leukocytes Quantitative/ratio 2.2–13,000 1473.96 1.82
Platelets Quantitative/ratio 1.71–459,000 113206.44 1.82
Albumin Quantitative/ratio 1.9–4.9 3.45 3.64
Total Bil Quantitative/ratio 0.3–40.5 3.09 3.03
ALT Quantitative/ratio 11–420 67.09 2.42
AST Quantitative/ratio 17–553 69.38 1.82
GGT Quantitative/ratio 23–1575 268.03 1.82
ALP Quantitative/ratio 1.28–980 212.21 1.82
TP Quantitative/ratio 3.9–102 8.96 6.67
Creatinine Quantitative/ratio 0.2–7.6 1.13 4.24
Number of nodules Quantitative/ratio 0–5 2.74 1.21
Major dimension Quantitative/ratio 1.5–22 6.85 12.12
Dir. bil Quantitative/ratio 0.1–29.3 1.93 26.67
Iron Quantitative/ratio 0–224 85.6 47.88
Sat Quantitative/ratio 0–126 37.03 48.48
Ferritin Quantitative/ratio 0–2230 439 48.48
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base aimed at both minimizing the loss of clinical records and
the distortion of the results in the later prediction stages. Accord-
ing to the literature [24,14,25], the most two conventional
approaches used for managing missing data are to delete or impute
values. By far, the most widely-used approach to missing data is
the elimination of cases with unknown values. However, this pro-
cedure has been ruled out from the beginning, since 157 of 165
patients are incomplete. Then, an imputation-based approach
had to be considered. Imputation is the process of replacing a miss-
ing datum with a substitute value [24], which is estimated using
the available information in the database. This is an advantage
compared to discarding incomplete cases, since imputing missing
values provides additional information that can ease the later pre-
diction stages and, thus, enhance the obtained results [9,10,26–28].
From the different imputation methods of the literature [14], we
have chosen a nearest neighbor approach, which has shown its
usefulness in many other clinical studies with missing values
[29–31]. Initially, other simple statistical data imputation methodswere tested, specifically mean/mode imputation and median
imputation, which were found to add a distortion to the input data
distribution. While these two methods ignore the relation between
variables to perform imputation, KNN is a local approximation for
imputation and, the, it is able to maintain the original input data
distribution with a proper selection of K (in our case, K ¼ 1). In this
imputation approach, for each incomplete case x, its closest neigh-
bor v is chosen from those training samples with available infor-
mation in the features to be imputed. This requires the
computation of distances between each incomplete case and all
the training samples, according to a similarity metric. We have
used the Heterogeneous Euclidean-Overlap Metric (HEOM) dis-
tance [32], which efficiently handles both continuous and discrete
variables in a missing data framework. Considering two input
vectors, xA and xB, the HEOM distance can be calculated by [32]:dðxA;xBÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXn
j¼1djðxAj; xBjÞ
2
r
; ð1Þ
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bute, where
djðxAj; xBjÞ ¼
1; if xj is missing in xA or xB;
dOðxAj; xBjÞ; if xj is a discrete variable;
dNðxAj; xBjÞ; if xj is a continuous variable:
8><
>: ð2Þ
In Eq. (2), it is considered that the distance varies from 0 to 1
(the maximal distance value). If either one of the input values is
missing in the j-th variable, its distance is 1. If both input values
are available, HEOM uses the overlap metric, dO, for categorical
attributes (Eq. (3)) and the normalized Euclidean distance, dN , for
continuous attributes (Eq. (4)):
dOðxAj; xBjÞ ¼
0; if xAj ¼ xBj;
1; otherwise;

ð3Þ
dNðxAj; xBjÞ ¼
xAj  xBj
 
maxðxjÞ minðxjÞ : ð4Þ
Once the closest neighbor is found (v), each unknown value in x
is replaced by the corresponding available feature value of v. At
this point, it should be noted that (I) the closest neighbor imputa-
tion approach has been applied in order to maintain the variability
of the dataset; and (II) there is not any previous research work
about imputation for HCC databases with missing values. Finally,
at the end of the data imputation stage, all features are standard-
ized using the well-known Z-Score transformation [33].
3.3. Cluster-based oversampling
Once the data is cleaned, we try to find naturally occurring
clusters (or groups) within our HCC database. Each group will be
composed of several patient samples with similar feature values.
As it is explained next, this work uses the GAP statistic [34] to
automatically choose the number of groups (K) and, then, cluster-
ing is performed using the K-means algorithm.
3.3.1. Clustering patients using K-means
Due to the nature of the available data, its efficiency and success
in several fields of pattern recognition [35], particularly for
clustering cancer data [36,37], and its application potential to
cluster-based sampling algorithms [38], we have chosen to apply
K-means algorithm to cluster the HCC dataset.
K-means is a well-known unsupervised learning algorithm for
data partition with low computational cost for high-dimensional
datasets [39,35]. For a given number of groups (K), this method
finds K centroids, ckf gKk¼1, in order to place them as much as possi-
ble far away from each other. Those samples with the same nearest
centroid are included in the same group: Ck. K-means iteratively
minimizes the sum of distances from each object to its centroid,
over all clusters. In particular, the following error function is
minimized [35]:
J ¼
XK
k¼1
X
xi2Ck
dðxi; ckÞ; ð5Þ
where dðxi; ckÞ denotes the distance from the i-th input sample to
the k-th centroid.
In the K-means algorithm, it is needed to perform an appropri-
ate initialization of the centroids [35]. Bad initialization leads to
suboptimal solutions with poor results. In order to avoid this draw-
back, our methodology uses the K-means++ procedure [40], which
provides a robust initialization that leads to a competitive solution
for the data partition. Another user-specified parameter is the
number of clusters (K), which is a critical choice for the resulting
partition [35]. Although there is not a theoretical criterion forselecting this parameter, the GAP statistic allows to find the proper
K for K-means clustering [34]. It is a commonly used approach in
practice which automatically provides very competitive results.
According to Tibshirani et al. [34], and given that the sum of dis-
tances between the Nk points in Ck is Dk ¼
P
xA ;xB2CkdðxA;xBÞ, the
intra-cluster variance, WK ¼
PK
k¼1
1
2Nk
Dk, gives a measure of the
compactness of our clustering. WK can be used to heuristically
determine the optimal K: considering a range of possible values
for K, the evolution of WK with respect to the number of clusters
is plotted and, then, the most dramatic decrease (‘‘elbow”) in the
plot is found for the optimal value of K. The gap statistic formalizes
this heuristic procedure and it automatically provides the optimal
K [34]. To assess the optimal number of clusters for the HCC
dataset, the gap statistic was calculated for a range of 2–30
clusters. The optimal number of clusters was found for K ¼ 10
clusters.
An important issue is that different runs (initializations of K
centroids) of K-means give different partitions. For overcoming this
inconvenient in practice, multiple different initializations are con-
sidered and, from its K-means solutions, the partition with the
smallest error is selected as final [35]. In contrast, several works
have implemented ensembles methods by combining multiple
partitions to obtain an integrated partition using a consensus func-
tion [41–44]. Nevertheless, in our approach, the aim is not to
achieve a unique clustering. As it is explained next, our proposed
methodology exploits the diversity of the multiple obtained
partitions for constructing an augmented dataset in a two-phase
sampling procedure.3.3.2. First sampling phase: balancing groups by synthetic samples
In this first stage, oversampling is applied in order to diminish
the impact of underlying patient groups/profiles with reduced
sizes on survival prediction. In most clinical databases, several
patient profiles can be found and, naturally, with different sizes.
In terms of groups, a database is imbalanced if its underlying clus-
ters are not approximately equally represented. As it is shown in
our experiments, a high imbalance in the sizes of the patient pro-
files hinders the design of survival prediction models. For most
imbalanced datasets, the application of sampling techniques
improves classifier accuracy. Random oversampling and under-
sampling are two of the most common sampling techniques [16].
Oversampling augments the original set of samples by randomly
replicating minority class examples. Undersampling removes
majority class examples from the original set. Both of these algo-
rithms achieve class balance, but can also potentially hinder the
learning task: oversampling does not incorporate any new infor-
mation and may lead to overfitting, while undersampling may
remove important examples to the learning step, causing the
classifier to miss important concepts [38].
To avoid this drawback, this work takes advantage of the
SMOTE algorithm [16], which is the most popular and applied
oversampling procedure. SMOTE algorithm generates synthetic
minority samples, based on the similarity between the available
minority samples, considering it’s K-nearest neighbors [38]. In par-
ticular, we have also implemented a cluster-based approach which
follows the same principles of SMOTE. In the original version of
SMOTE, this algorithm is used to oversample the minority class
label, which means the class of the newly generated synthetic
samples is already previously established. In our implemented
approach, SMOTE has been adapted to oversample clusters with
reduced sizes. Some clusters may contain different class labels.
Thus, the assessment of the class label for each new synthetic sam-
ple is done according to a random number between 0 and 1, call it
u, used in the original SMOTE implementation to create each new
synthetic sample.
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main steps:
1. Selection of clusters with reduced sizes. Instead of balancing all
groups to the largest one, the size reference is established to
the second largest cluster (this criteria was chosen after per-
forming some preliminary experiments). Then, oversampling
is performed in those clusters with lower sizes than this
reference.
2. Generation of synthetic samples. Within each cluster Ck of
reduced size:(a) Consider each sample x in the cluster. Note that if
amount of oversampling (relationship between the samples
to be generated and the existing ones) does not require the
oversampling of all the existing samples, the samples to
oversample are chosen randomly.
(b) Choose one of its V nearest neighbors, v. In this work,
several different values of V were tested, from 1 to 5 nearest
neighbors. V ¼ 3 has provided the best results (considering
the complete experimental setup), and thus it was used as
the appropriate number of neighbors to SMOTE.
(c) Create a new synthetic sample s according to SMOTE’s
equation:
s ¼ xþuðx vÞ; ð6Þ
being u a random number between 0 and 1.
(d) The class label (survival status) of s is assigned according
tou. Ifu is greater than 0.5, the class label of s is the same asFig. 2. First sampling phase: balancing groupv. On the contrary, if u is smaller or equal to 0.5, the class
label of s is the same as x.
(e) Step (c) is repeated according to the amount of oversam-
pling required.
It should be noted that the above procedure is repeated for each
obtained partition in the K-means clustering. Fig. 2 depicts a
scheme of this first sampling phase, where there is also shown
the previous stages of data imputation and clustering of the dataset
D. Let us assume that R runs of K-means have been done, where the
value of K has been previously determined using the GAP statistic.
For the r-th run, with r ¼ 1;2; . . . ;R, its obtained partition is
defined by K different clusters: Cr;k
 K
k¼1. Those clusters with
reduced sizes are oversampled:
Cr;k
n oK
k¼1
¼ Cr;k [ Sr;k
 K
k¼1; ð7Þ
being Sr;k the subset of generated samples for the k-th group in the
r-th partition. Therefore, at the end of this first sampling phase, we
have R different datasets: Dr
 R
r¼1, where Dr ¼ [kCr;k.
3.3.3. Second sampling phase: construction of a representative dataset
In this second sampling phase, the goal is to exploit the
diversity of the different generated sets, D1;D2; . . . ;DR, to obtain
an augmented dataset, M, which provides a better representation
of the survival prediction problem. This work considers and evalu-
ates two sampling schemes for merging the information from thes by the generation of synthetic samples.
Fig. 3. Second sampling phase: construction of a representative dataset.
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is defined by merging R data portions which have been sampled
from Dr
 R
r¼1. The resulting dataset, M, is used to model survival
prediction for HCC disease. In this work, each data portion is com-
posed of 20% of samples from Dr , following the principles of strat-
ified random sampling method [45]. This ratio provides a
representative contribution of each oversampled dataset and it
has been chosen according to our experience in the HCC dataset.
This sample scheme is illustrated in Fig. 3.
Based on this first sampling scheme, and instead of providing a
single representative dataset (M), we also implement another
combination approach which finally produces R augmented data-
sets, Mrf gRr¼1. In particular, Mr is composed of Dr and R 1 por-
tions of samples of the remaining oversampled datasets. Here,
the same percentage of sampling is considered (20%) for each por-
tion. With respect to survival prediction, in this second sampling
scheme, R different models have to be designed using each repre-
sentative dataset and, as it is explained next, their resulting R
predictions are combined using majority voting.
3.4. Survival prediction
In this work, two well-known classification methods are applied
[39]: Neural Networks (NN) and Logistic Regression (LR). These
classifiers have shown their usefulness for survival prediction in
previous research works with HCC data [21,23,22]. For each one
of them, this work studies the impact of using the different gener-
ated datasets obtained with our cluster-based oversampling
method on survival prediction for HCC disease.
4. Experiments
The proposed methodology has been experimentally evaluated
using the HCC dataset, which has been previously described in
SubSection 3.1. The experiments were performed in order to show
that our proposed methodology is generally feasible to design sur-
vival prediction models for HCC disease and, also, that it outper-
forms other widely-used approaches. In this work, we have
carried out a series of simulations, considering four different
approaches. In the first approach, survival prediction models (for
NN and LR) are developed using directly the dataset obtained from
the data imputation stage, D (Without Cluster, No-Oversampling).
For the second approach, the minority class in D is oversampled
using the SMOTE algorithm (Without Cluster, Oversampling). Then,
the same two classification algorithms are used. Note that, in this
second approach, we analyze the impact of overcoming the class-
imbalance in D on classification. In the third and fourth
approaches, our methodology is applied. The third approachobtains a unique representative dataset M using the proposed
cluster-based oversampling method, which has been described in
SubSection 3.3 (With Cluster, Representative Set Approach). After
that, M is used for constructing a survival prediction model using
each classification algorithm. Finally, instead of providing a unique
dataset M, the fourth approach obtains R augmented datasets,
M1;M2; . . . ;MR (With Cluster, Augmented Sets Approach). For
each one of them and for each classification algorithm, a survival
prediction model is constructed. Then, the classification results
obtained from the R models trained with the same classification
method are combined by a majority voting scheme.
Experiments have been performed using a Leave-One-Out Cross
Validation (LOO-CV) process for performance evaluation [39],
which is appropriate since the amount of available data is not
large. This evaluation scheme also avoids undesirable shifts from
the random selection of training and test sets. Specifically, for the
N total number of samples involved in the study, one is left out
for testing, and the remaining N  1 are used for designing the
survival prediction models. For each iteration of the LOO-CV proce-
dure, thirty runs of the cluster-oversampling were performed.
All simulations have been carried out in MATLAB 8.2 (R2013b)
environment running in the same machine.
To perform the evaluation of each classifier (NN and LR), three
different measures were used: Accuracy, AUC and F-Measure. Tra-
ditionally, the most widely-used performance measure in classifi-
cation problems is Accuracy. However, it ignores the probability
estimations of classification in favor of class labels. In many
research areas, and particularly biomedical applications, two addi-
tional performance measures based on the confusion matrix and
the ROC (Receiver Operator Curve) are usually applied: AUC (area
under the ROC curve) and F-measure. In one hand, the area under
the ROC curve (AUC) is a measure of how well a classification
model can distinguish between two diagnostic groups (diseased/
normal). In practice, the AUC is often used when a representative
measure of discrimination is needed and it can even replace the
Accuracy as a performance measure [46]. In the other hand, the
F-measure is defined as the harmonic mean of Precision (or the
Positive Predictive Value) and Recall (or Sensitivity or True Positive
Rate) and, then, it provides a balance between both performance
metrics. For each one of these metrics, three indicators were used:
Mean, Standard deviation (Std) and Rank. The first two indicators,
Mean and Std, are computed from the obtained experimental
results with the different configurations of the classification meth-
ods (i.e. different hidden layer sizes for the NN classifier and differ-
ent thresholds for the LR classifier). According to the work
proposed by Demsar [47], the third indicator is the Rank obtained
by a Friedman rank test, which was used to compare the obtained
performance results (Accuracy/AUC/F-measure) in the four tested
approaches regarding both classifiers. Tables 3 and 4 respectively
Table 3
Neural Networks (NN) performance evaluation using Accuracy, AUC and F-Measure. For each measure, three indicators were used: mean and standard deviation (std) for the best
configuration of each approach and the Rank of the Friedman rank test.
Approach Accuracy AUC F-Measure
Mean Std Rank Mean Std Rank Mean Std Rank
Without cluster
No-oversampling 0.687 0.043 4 0.650 0.068 3.8 0.550 0.075 4
Oversampling 0.717 0.038 2.91 0.661 0.034 3.2 0.645 0.027 2.73
With cluster
Representative set approach 0.737 0.023 2.09 0.689 0.021 2 0.640 0.034 2.27
Augmented sets approach 0.752 0.011 1 0.700 0.015 1 0.665 0.018 1
Table 4
Logistic Regression (LR) performance evaluation using Accuracy, AUC and F-Measure. For each measure, three indicators were used: mean and standard deviation (std) for the
best configuration of each approach and the Rank of the Friedman rank test. It should be noted that for Without Cluster and No-Oversampling, std values are not applicable, n.a.
Approach Accuracy AUC F-Measure
Mean Std Rank Mean Std Rank Mean Std Rank
Without cluster
No-oversampling 0.721 n.a 2.4 0.658 n.a 2 0.651 n.a 2.6
Oversampling 0.706 0.010 3 0.649 0.007 3 0.639 0.012 3.2
With cluster
Representative set approach 0.725 0.016 2.6 0.668 0.014 3 0.648 0.020 2.4
Augmented sets approach 0.730 0.014 2 0.673 0.012 2 0.652 0.016 1.8
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each classifier, NN and LR. Due to space limitations and to make
easier the experimentation analysis for the reader, in Tables 3
and 4, the first two indicators, Mean and Std, are related to the best
results achieved by each of the classifier configurations; and,
meanwhile, the third indicator, Rank, is related to the final ranking
of the Friedman test. For more detailed information about simula-
tion results, please consult Appendix A.
Table 3 illustrates the obtained results by NN classifier. From
the analysis of the table, it is easy to note that using any of the
evaluation measures (Accuracy, AUC and F-Measure) and only
the first two indicators (mean and std), Augmented Sets Approach
presented the best results in comparison to the other three
approaches.
As concerns the NN classifier, eleven distinct network configu-
rations were used in the experience (5–55 hidden neurons in a step
of 5) and for each hidden layer size, 30 runs were performed. For
Friedman rank test, each group represents the average Accuracy
of each considered configuration of neurons for each of the four
used approaches. The average of the results of each approach is
compared to all other approaches and, following the work pre-
sented by Demsar [47], Ff = 7.691 was calculated and compared
to the F distribution (3, 30) = 2.92 with a significance level of
a ¼ 0:5. As consequence, the null hypothesis of equivalence
between the four approaches is rejected. Comparing all the four
approaches for a 5% significance level using the Nemenyi test
[47], it was possible to obtain CD = 1.4142. CD is the critical value
for the difference of mean ranks between the four approaches.
Attending to Table 3, Augmented Sets Approach performed better
than the approaches that did not use cluster strategy. Also,
Representative Set Approach performed better than the first two
approaches that can be considered widely-used approaches. These
findings follow the ones previously detected for the other indica-
tors (mean and std).
Regarding the other classification method (LR), the same
analysis was performed. Table 4 illustrates the Accuracy results
for LR classifier. Mean and std represent the best results presented
by each approach related to a specific threshold. Once again,
Augmented Sets Approach presented better results than the otherthree approaches. It should be noted that for the first approach
(Without Cluster, No-Oversampling), the LR model always
produces the same results, since there are not any random factors
considered in this method (the input data is always the same).
Thus, only one run was performed and, then, std measure is not
applicable (n.a.) for this first approach. The other three approaches
consider oversampling of cases, which implies adding random fac-
tors to the procedure (chosen nearest neighbor, random number
u), and thus, similarly to the NN case, 30 runs of these approaches
were also performed. To produce the rank mean value, each group
corresponds to one of the five different thresholds used (0.5–0.9)
and, for each configuration, 30 runs were performed (as in Table 3,
only the final rank mean was displayed). Again, for this scenario
Ff = 7.800 was calculated and compared to the F distribution (3,
12) = 3.4903 with a significance level of a ¼ 0:5. Consequently,
the null hypothesis of equivalence between the four approaches
is rejected. Comparing all the four approaches for a 5% significance
level using the Nemenyi test [47], it was possible to obtain
CD = 2.0976. With respect to Table 4, none of the approaches
proved to be better than the others using Rank as indicator.
Finally, in spite of the fact that the related works illustrated on
Section 2.2 did not cover the same topic as our proposed approach,
and due to that they cannot be directly compared, for our best
approach (Augmented Sets Approach), the Sensitivity and Speci-
ficity values for both algorithms (NN and LR) are in the range of
the previously published results. For NN and LR, the sensitivity
results were 0.647 and 0.741 and, for specificity, the results were
0.827 and 0.777 respectively.5. Conclusions and future work
In this work, a new methodology capable of predicting the 1-
year survival for patients with HCC has been presented. To achieve
that, a HCC dataset composed by 165 patients followed in an uni-
versity hospital center was used. At the beginning of the study, this
dataset presented three main challenges: its heterogeneity con-
cerning the type of considered variables (49 features were used
encompassing dichotomous, ratio scaled and ordinal features),
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tutes 10.22% of the total data with only eight patients having com-
plete information) and, finally, the data unbalance observed, that
made even more difficult to create a valid methodology to predict
1-year survival for patients with HCC. The proposed methodology
relied on a cluster-based oversampling approach where two classi-
fiers (NN and LR) were separately used in two novel approaches,
referred to as Representative Set Approach and Augmented Sets
Approach, and compared with two widely-used approaches
(explained in the previous sections). The main difference of these
two sets of approaches consists in using a new cluster-based
methodology that addresses the challenges previously detected
at the beginning of the study.
The achieved results were assessed using three performance
measures: Accuracy, AUC and F-measure. To compare the obtained
results of the four used approaches for each classifier, Friedman
rank test was used as proposed in Demsar’s work [47]. The pro-
posed methodology coupled with NN classifier presented better
results than the other two widely-used approaches regarding all
the performance measures previously defined, proving that our
methodology provides a more appropriate approach to design sur-
vival prediction models in a HCC context with the discussed
characteristics.
There are two possible directions for future works: the applica-
tion of the proposed methodology to other medical and non-
medical classification problems; and its extension to estimate
missing values in the input data.
To the extent of authors’ knowledge, this methodology has
never been proposed or applied in HCC dataset in particular, or
other diseases or subjects in general. Thus, the issue of repro-
ducibility and generalization for other contexts has not yet beenTable 5
Obtained Accuracy results (mean ± standard deviation) in the HCC dataset using NN archi
Number of neurons Without cluster
No-oversampling Oversampling
5 0.6525 ± 0.0314 0.6927 ± 0.0211
10 0.6709 ± 0.0210 0.7016 ± 0.0257
15 0.6659 ± 0.0228 0.7077 ± 0.0282
20 0.6869 ± 0.0432 0.7006 ± 0.0228
25 0.6814 ± 0.0450 0.7170 ± 0.0379
30 0.6618 ± 0.0283 0.6956 ± 0.0289
35 0.6602 ± 0.0230 0.6842 ± 0.0330
40 0.6632 ± 0.0397 0.6947 ± 0.0195
45 0.6352 ± 0.0270 0.6768 ± 0.0326
50 0.6406 ± 0.0273 0.6768 ± 0.0240
55 0.6412 ± 0.0243 0.6788 ± 0.0272
Table 6
Obtained AUC results (mean ± standard deviation) in the HCC dataset using NN architectu
Number of neurons Without cluster
No-oversampling Oversampling
5 0.6179 ± 0.0332 0.6377 ± 0.0179
10 0.6353 ± 0.0209 0.6465 ± 0.0200
15 0.6267 ± 0.0259 0.6467 ± 0.0252
20 0.6473 ± 0.0397 0.6452 ± 0.0180
25 0.6435 ± 0.0434 0.6610 ± 0.0343
30 0.6279 ± 0.0300 0.6432 ± 0.0230
35 0.6729 ± 0.0287 0.6310 ± 0.0271
40 0.6502 ± 0.0682 0.6391 ± 0.0157
45 0.6022 ± 0.0369 0.6257 ± 0.0260
50 0.6046 ± 0.0323 0.6265 ± 0.0196
55 0.6061 ± 0.0287 0.6304 ± 0.0233addressed. This topic could be a possibility for future work:
extending our methodology to other contexts besides HCC disease,
whether they are healthcare contexts or not.
Another ongoing work is the application of the proposed
methodology to MD imputation. The implemented cluster-
based oversampling algorithm could be adapted to estimate
missing values. In this work, the data in each cluster is complete
and the new synthetic samples are generated as explained in
Section 3.3.2. Considering incomplete data in the clusters, a mod-
ification of our algorithm would be used to generate new sam-
ples, where each missing value is replaced. Then, these newly
generated samples could be used in our cluster-based approach
to impute the missing observation in the original dataset. Fol-
lowing the LOO-CV procedure, each missing value could be
replaced M times, and for each one of these M times, a classifier
would be used. The proper values to be imputed should be cho-
sen according to the set that allows the best classification
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Tables 5–10tectures with different hidden layer sizes (from 5 to 55).
With cluster
Representative set approach Augmented sets approach
0.7131 ± 0.0208 0.7477 ± 0.0160
0.7087 ± 0.0186 0.7396 ± 0.0251
0.7117 ± 0.0263 0.7493 ± 0.0106
0.7238 ± 0.0245 0.7360 ± 0.0220
0.7133 ± 0.0196 0.7436 ± 0.0126
0.7279 ± 0.0202 0.7519 ± 0.0105
0.7368 ± 0.0225 0.7461 ± 0.0153
0.7248 ± 0.0226 0.7420 ± 0.0207
0.7119 ± 0.0245 0.7392 ± 0.0193
0.7220 ± 0.0227 0.7360 ± 0.0232
0.7236 ± 0.0178 0.7453 ± 0.0202
res with different hidden layer sizes (from 5 to 55).
With cluster
Representative set approach Augmented sets approach
0.6626 ± 0.0215 0.6941 ± 0.0161
0.6573 ± 0.0205 0.6871 ± 0.0248
0.6633 ± 0.0239 0.6983 ± 0.0125
0.9731 ± 0.0203 0.6883 ± 0.0214
0.6652 ± 0.0199 0.6943 ± 0.0163
0.6754 ± 0.0221 0.6998 ± 0.0122
0.6887 ± 0.0210 0.7002 ± 0.0154
0.6757 ± 0.0195 0.6935 ± 0.0246
0.6646 ± 0.0256 0.6926 ± 0.0241
0.6754 ± 0.0231 0.6880 ± 0.0269
0.6762 ± 0.0163 0.6982 ± 0.0229
Table 8
Obtained accuracy results (mean ± standard deviation) in the HCC dataset using LR architectures with different thresholds (from 1 to 5). For without cluster, no-oversampling,
mean and std values are not applicable, n.a (4), but the corresponding values for this approach are 0.7030, 0.7091, 0.7030, 0.7212, 0.7152.
Number of neurons Without cluster With cluster
No-oversampling Oversampling Representative set approach Augmented sets approach
1 n.a. 0.7018 ± 0.0093 0.7248 ± 0.0158 0.7301 ± 0.0139
2 n.a. 0.7030 ± 0.0090 0.7220 ± 0.0163 0.7267 ± 0.0147
3 n.a. 0.7053 ± 0.0091 0.7109 ± 0.0166 0.7174 ± 0.0136
4 n.a. 0.7055 ± 0.0095 0.6986 ± 0.0169 0.6966 ± 0.0118
5 n.a. 0.7057 ± 0.0100 0.6721 ± 0.0163 0.6733 ± 0.0124
Table 9
Obtained AUC results (mean ± standard deviation) in the HCC dataset using LR architectures with different thresolds (from 1 to 5). For without cluster, no-oversampling, mean
and std values are not applicable, n.a (4), but the corresponding values for this approach are 0.6520, 0.6535, 0.6476, 0.6585, 0.6528.
Number of neurons Without cluster With cluster
No-oversampling Oversampling Representative set approach Augmented sets approach
1 n.a. 0.6489 ± 0.0074 0.6683 ± 0.0137 0.6725 ± 0.0124
2 n.a. 0.6483 ± 0.0072 0.6613 ± 0.0139 0.6662 ± 0.0135
3 n.a. 0.6485 ± 0.0069 0.6477 ± 0.0130 0.6541 ± 0.0110
4 n.a. 0.6470 ± 0.0074 0.6351 ± 0.0122 0.6340 ± 0.0085
5 n.a. 0.6445 ± 0.0081 0.6137 ± 0.0109 0.6144 ± 0.0082
Table 10
Obtained F-Measure results (mean ± standard deviation) in the HCC dataset using LR architectures with different thresolds (from 1 to 5). For without cluster, no-oversampling,
mean and std values are not applicable, n.a (4), but the corresponding values for this approach are 0.6080, 0.6250, 0.6202, 0.6515, 0.6466.
Number of neurons Without cluster With cluster
No-oversampling Oversampling Representative set approach Augmented sets approach
1 n.a. 0.6119 ± 0.0117 0.6417 ± 0.0211 0.6489 ± 0.0187
2 n.a. 0.6181 ± 0.0127 0.6483 ± 0.0196 0.6518 ± 0.0154
3 n.a. 0.6253 ± 0.0133 0.6471 ± 0.0196 0.6509 ± 0.0164
4 n.a. 0.6305 ± 0.0129 0.64445 ± 0.0182 0.6407 ± 0.0133
5 n.a. 0.6385 ± 0.0142 0.6326 ± 0.0168 0.6339 ± 0.0127
Table 7
Obtained F-Measure results (mean ± standard deviation) in the HCC dataset using NN architectures with different hidden layer sizes (from 5 to 55).
Number of neurons Without cluster With cluster
No-oversampling Oversampling Representative set approach Augmented sets approach
5 0.4780 ± 0.0548 0.6134 ± 0.0277 0.6184 ± 0.0301 0.6620 ± 0.0199
10 0.5194 ± 0.0372 0.6178 ± 0.0363 0.6169 ± 0.0224 0.6517 ± 0.0308
15 0.5297 ± 0.0463 0.6446 ± 0.0270 0.6107 ± 0.0394 0.6604 ± 0.0141
20 0.5496 ± 0.0754 0.6185 ± 0.0322 0.6279 ± 0.0395 0.6384 ± 0.0324
25 0.5345 ± 0.0803 0.6361 ± 0.0457 0.6128 ± 0.0250 0.6515 ± 0.0138
30 0.4940 ± 0.0551 0.6059 ± 0.0391 0.6385 ± 0.0315 0.6650 ± 0.0182
35 0.4876 ± 0.0412 0.6056 ± 0.0378 0.6399 ± 0.0340 0.6490 ± 0.0228
40 0.4590 ± 0.0452 0.6160 ± 0.0261 0.6255 ± 0.0469 0.6499 ± 0.0208
45 0.4473 ± 0.0373 0.5942 ± 0.0375 0.6110 ± 0.0291 0.6433 ± 0.0198
50 0.4598 ± 0.0507 0.5883 ± 0.0322 0.6202 ± 0.0343 0.6415 ± 0.0256
55 0.4619 ± 0.0360 0.5823 ± 0.0412 0.6220 ± 0.0333 0.6508 ± 0.0259
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